Trial Summary
The trial protocol does not specify if you need to stop taking your current medications. However, you must be on a stable dose of any medications that may affect sleep or PSG, like sedatives or hypnotics.
The available research shows that the ExVent Accessory, which is a nasal valve device, was tested in a pilot study and found to improve breathing during sleep for people with obstructive sleep apnea. This suggests it could be an effective treatment option. However, the study was a pilot, meaning it was small and preliminary, so more research is needed to confirm these results. Compared to other treatments like oral appliances and elevated posture, which also aim to improve airway function, the ExVent Accessory offers a different approach by using expiratory resistance to aid breathing.
12345The provided research does not contain specific safety data for the ExVent treatment or its variants. The articles focus on general adverse event reporting and management for medical devices, but do not mention ExVent, ExVent Accessory, or ExVent Valve specifically.
678910Yes, the ExVent Accessory, which uses a nasal expiratory resistance device, shows promise as a treatment for obstructive sleep apnea. It helps improve breathing during sleep by using a special valve that makes it easier to breathe out, which can be beneficial for people with sleep apnea.
1241112Eligibility Criteria
This trial is for adults aged 22 or older with mild to moderate obstructive sleep apnea, who have been using the O2Vent Optima device regularly. Participants must not be in other studies, pregnant, or have conditions affecting oral appliance use. They should not have had significant weight changes recently and must avoid high caffeine or alcohol intake.Inclusion Criteria
Exclusion Criteria